World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
16856
World Ranking
2008
National Ranking
985

Medicine

D-Index
75
Citations
16856
World Ranking
19215
National Ranking
9571

Michael A. Kaliner publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael A. Kaliner sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 328 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael A. Kaliner D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael A. Kaliner sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael A. Kaliner is affiliated with the National Institutes of Health in the United States and has contributed extensively to medical research, with a specialization in immunology and allergy, pharmacology, and related subfields. Their work spans 57 publications primarily in medicine, with significant focus on immunology and allergy, as well as pharmacological and physiological studies.

Their research frequently appears in notable scientific journals, including the Journal of Allergy and Clinical Immunology, where they have published 15 articles. Other prominent venues for their work include the Annals of Allergy Asthma & Immunology with 6 publications, the The Journal of Allergy and Clinical Immunology In Practice with 3 publications, and more specialized outlets such as Pharmaceutics and Journal of Allergy and Clinical Immunology Global.

Kaliner's recent research outputs provide insight into their focus on epinephrine and its pharmacokinetics and pharmacodynamics in allergy treatments. Selected recent papers include:

  • Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions (2024), Pharmaceutics
  • Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection (2023), Journal of Allergy and Clinical Immunology
  • Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg versus manual intramuscular epinephrine 0.3 mg by health care provider (2023), The Journal of Allergy and Clinical Immunology In Practice
  • Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly (2022), Annals of Allergy Asthma & Immunology
  • Comparison of the pharmacokinetics between intramuscular and subcutaneous manual epinephrine administration (2022), Annals of Allergy Asthma & Immunology

Their research interests are reflected in the main topics they cover in their publications, which include:

  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Drug-Induced Adverse Reactions
  • Pharmaceutical studies and practices
  • Respiratory and Cough-Related Research
  • Intramuscular injections and effects

Frequent co-authors who have collaborated with Kaliner provide a network of expertise in similar domains. These co-authors include:

  • Sarina Tanimoto
  • Richard Lowenthal
  • Richard F. Lockey
  • Thomas B. Casale
  • Richard Löwenthal

Kaliner's research contributes primarily to understanding allergic reactions and improving treatments related to epinephrine administration, with systemic exploration of intramuscular versus intranasal delivery methods. This work intersects pharmacological, clinical, and physiological research fields to address allergy-related healthcare challenges.

Best Publications

  • Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders

    Nancy F. Ray;James N. Baraniuk;Mae Thamer;Cheryl S. Rinehart

  • Slow-Reacting Substances, Leukotrienes C4 and D4, Increase the Release of Mucus from Human Airways in vitro1,2

    Zvi Marom;J. H. Shelhamer;M. K. Bach;D. R. Morton

  • Effects of Arachidonic Acid, Monohydroxyeicosatetraenoic Acid and Prostaglandins on the Release of Mucous Glycoproteins from Human Airways In Vitro

    Zvi Marom;James H. Shelhamer;Michael Kaliner

  • Immunologic and Neuropharmacologic Stimulation of Mucous Glycoprotein Release from Human Airways In Vitro

    James H. Shelhamer;Zvi Marom;Michael Kaliner

  • Asthma : its pathology and treatment

    Michael A. Kaliner;Peter J. Barnes;C. G. A. Persson

  • Differential Metabolism of Arachidonic Acid in Nasal Polyp Epithelial Cells Cultured from Aspirin-sensitive and Aspirin-tolerant Patients

    Marek L. Kowalski;Rafal Pawliczak;Janina Wozniak;Katarzyna Siuda

  • Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: Evidence for opiate and nonopiate receptor participation

    Thomas B. Casale;Scott Bowman;Michael Kaliner

  • Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells.

    Michael Kaliner;K. Frank Austen

  • Human airway monohydroxyeicosatetraenoic acid generation and mucus release.

    Zvi Marom;James H. Shelhamer;Frank Sun;Michael Kaliner

  • Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients

    Bernard L. Mosimann;Martha V. White;Robert J. Hohman;Michael S. Goldrich

  • Autonomic Nervous System Abnormalities and Allergy

    M Kaliner;J H Shelhamer;P B Davis;L J Smith

  • Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma

    Andrew R. Fischer;Mitchell A. Rosenberg;Craig M. Lilly;Joan C. Callery

  • Diagnosis and management of rhinosinusitis: a practice parameter update.

    Anju T. Peters;Sheldon Spector;Joy Hsu;Daniel L. Hamilos

  • Substance P and neurokinin A in human nasal mucosa

    James N. Baraniuk;Jens D. Lundgren;Michiko Okayama;Julie Goff

  • Alpha-Adrenergic Hyper-Responsiveness in Asthma

    Henderson Wr;Shelhamer Jh;Reingold Db;Smith Lj

  • Effects of infused histamine: Correlation of plasma histamine levels and symptoms

    Michael Kaliner;James H. Shelhamer;Eric A. Ottesen

  • Uric acid is a major antioxidant in human nasal airway secretions.

    David B. Peden;Robert Hohman;Mary E. Brown;Robert T. Mason

  • Immunologic release of chemical mediators from human nasal polyps.

    Kaliner M;Wasserman Si;Austen Kf

  • Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses

    Nancy F. Ray;James N. Baraniuk;Mae Thamer;Cheryl S. Rinehart

  • The Effects of the Immunologic Release of Histamine upon Human Lung Cyclic Nucleotide Levels and Prostaglandin Generation

    Leslie F. Platshon;Michael Kaliner

  • Sinusitis: Bench to bedsideCurrent findings, future directions

    M Kaliner;J Osguthorpe;P Fireman;J Anon

Frequent Co-Authors

James H. Shelhamer
James H. Shelhamer National Institutes of Health
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Dean D. Metcalfe
Dean D. Metcalfe National Institute of Allergy and Infectious Diseases
Erkka Valovirta
Erkka Valovirta University of Turku
Joaquim Mullol
Joaquim Mullol University of Barcelona
Richard F. Lockey
Richard F. Lockey University of South Florida
Anthony J. Frew
Anthony J. Frew Royal Sussex County Hospital
Peter J. Barnes
Peter J. Barnes Imperial College London
Marek L. Kowalski
Marek L. Kowalski Medical University of Lodz
F. Estelle R. Simons
F. Estelle R. Simons University of Manitoba

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens numerous pathways in healthcare and research, especially when combined with advanced nursing degrees. For those interested in mental health, exploring affordable pmhnp programs provides a cost-effective route to specialize as a Psychiatric-Mental Health Nurse Practitioner.

Understanding the financial landscape is essential; insights into dnp salary transparency help prospective students gauge potential earnings and regional salary variations for Doctor of Nursing Practice holders.

Nurses looking to expand their clinical expertise can benefit from bridge programs. The fnp to acnp bridge program online is a convenient option for Family Nurse Practitioners aiming to transition into Acute Care roles.

Additionally, accelerated pathways such as accelerated rn to np programs allow Registered Nurses to fast-track their education and enter advanced practice roles more quickly, complementing immunology-focused healthcare careers.

Best Scientists Citing Michael A. Kaliner

Trending Scientists

Recently Published Articles